Evidence map›Paper›PMID 37554055›Full record

ReviewBiochemistry2023

Structural Framework for Analysis of CD4+ T-Cell Epitope Dominance in Viral Fusion Proteins.

Samuel J Landry, Ramgopal R Mettu, Jay K Kolls, Judith H Aberle, Elizabeth Norton, Kevin Zwezdaryk, James Robinson

Open access · hybridAbstract readReview
In one paragraph

Review in Biochemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Samuel J LandryDepartment of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, Louisiana 70112, United States.ORCID 0000-0002-4082-0543
Ramgopal R MettuDepartment of Computer Science, Tulane University, New Orleans, Louisiana 70118, United States.ORCID 0000-0001-9479-9156
Jay K KollsJohn W. Deming Department of Internal Medicine, Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, Louisiana 70112, United States.
Judith H AberleCenter for Virology, Medical University of Vienna, 1090 Vienna, Austria.
Elizabeth NortonDepartment of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, Louisiana 70112, United States.
Kevin ZwezdarykDepartment of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, Louisiana 70112, United States.ORCID 0000-0001-8915-0715
James RobinsonDepartment of Pediatrics, Tulane University School of Medicine, New Orleans, Louisiana 70112, United States.
Tulane University · USMedical University of Vienna · AT

Funding

Tulane University COVID Antibody and Immunity Network (TUCAIN) SupplementU54CA260581 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI ROBINSON, JAMES E · 2020 to 2024
$9.2M
Training in CD4 T-cell Lung ImmunityR35HL139930 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI KOLLS, JAY K · 2018 to 2024
$6.3M
NCI NIH HHS U54 CA260581NHLBI NIH HHS R35 HL139930
6 · The paper itself

Abstract

Antigen conformation shapes CD4+ T-cell specificity through mechanisms of antigen processing, and the consequences for immunity may rival those from conformational effects on antibody specificity. CD4+ T cells initiate and control immunity to pathogens and cancer and are at least partly responsible for immunopathology associated with infection, autoimmunity, and allergy. The primary trigger for CD4+ T-cell maturation is the presentation of an epitope peptide in the MHC class II antigen-presenting protein (MHCII), most commonly on an activated dendritic cell, and then the T-cell responses are recalled by subsequent presentations of the epitope peptide by the same or other antigen-presenting cells. Peptide presentation depends on the proteolytic fragmentation of the antigen in an endosomal/lysosomal compartment and concomitant loading of the fragments into the MHCII, a multistep mechanism called antigen processing and presentation. Although the role of peptide affinity for MHCII has been well studied, the role of proteolytic fragmentation has received less attention. In this Perspective, we will briefly summarize evidence that antigen resistance to unfolding and proteolytic fragmentation shapes the specificity of the CD4+ T-cell response to selected viral envelope proteins, identify several remarkable examples in which the immunodominant CD4+ epitopes most likely depend on the interaction of processing machinery with antigen conformation, and outline how knowledge of antigen conformation can inform future efforts to design vaccines.

Indexed as

CD4-Positive T-LymphocytesEpitopes, T-LymphocyteAntigen PresentationHistocompatibility Antigens Class IIImmunodominant EpitopesViral Fusion ProteinsEpitopes, T-LymphocyteHistocompatibility Antigens Class IIImmunodominant EpitopesViral Fusion Proteins

Identifiers

PMID37554055
PMCPMC10483696
OpenAlexW4385684909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.